Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Life sciences

March 12, 2022 Life sciences

KLVFF oligopeptide-decorated amphiphilic cyclodextrin nanomagnets for selective amyloid beta recognition and fishing for selective amyloid beta recognition and fishing

Recognition and capture of amyloid beta is a challenging task for the early diagnosis of neurodegenerative disorders, such as Alzheimer’s

Continue reading

March 1, 2022 Analysis / Life sciences / Non-pharma applications

Beta-cyclodextrin filled analytical column will be carried again to Mars (by Rosalind Franklin rover).

In the near future ESA’s ExoMars mission plans to deliver the Rosalind Franklin rover onthe surface of Mars [1]. This

Continue reading

November 30, 2021 CD derivatives / Life sciences

Cyclodextrins Exert a Ligand-like Current Inhibitory Effect on the KV1.3 Ion Channel Independent of Membrane Cholesterol Extraction

Effects of CDs exerted on cellular functions are generally thought to originate from reductions in cholesterol levels. Potential direct, ligand-like

Continue reading

November 12, 2021 Life sciences

Phospholipid/methyl-ACD complex enhancing donor blood stability

Inventors Amir Farnoud and Amid Vahedi (Ohio University, US) have filed a patent application entitled “Methods for extending the shelf-life

Continue reading

November 11, 2021 Life sciences / Pharma applications

Role of HPBCD in development of Pfizer’s novel COVID-19 oral antiviral treatment candidate

Pfizer’s breakthrough drug candidate PF-07321332 used in combination with ritonavir was poven to successfully reduce the risk of hospitalization and

Continue reading

Posts navigation

«Previous Posts 1 2

Recent Posts

  • Recent books on cyclodextrins
  • β-cyclodextrin complexes with propolis and royal jelly components
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Methyl BCD alters cell envelop studied by AFM
  • Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (206)
  • CD derivatives (257)
  • Cosmetics and toilettry (21)
  • Drug delivery (437)
  • E-ducation (54)
  • Environmental (77)
  • Events (160)
  • Food (124)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (15)
  • Non-pharma applications (215)
  • Other industrial use (59)
  • Pharma applications (703)
  • Supramolecular systems (25)
  • Uncategorized (43)

Top Posts

  • Recent books on cyclodextrins
  • 7th European Cyclodextrin Conference
  • Lanosterol eye drops for cataract treatment
  • β-cyclodextrin complexes with propolis and royal jelly components
  • Website of EuroCD Conference is open
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • How air fresheners work?
  • Methyl BCD alters cell envelop studied by AFM
  • International Symposium of Drug Delivery Systems (SDDS-2022)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 524 other subscribers
 

Loading Comments...